The growing popularity of GLP-1 receptor agonists, especially semaglutide (Ozempic, Wegovy), has been accompanied by considerable social media attention and discussion, from which thorough analyses of user-generated data have emerged highlighting reductions in alcohol motivation, decreased drinking behavior, and altered subjective responses to alcohol (Arillotta et al
How to Avoid Ozempic Face During Weight Loss Ozempic has helped millions of people reach weight loss goals that felt out of reach for years
Featured product: GLP-1R/CRE (Luc) Reporter HEK293 Recombinant Cell Line This HEK293 cell line is engineered to produce a robust luciferase readout upon stimulation of the GLP-1R at the cell surface
What Recent Human Studies Reveal About Thyroid Safety Recent epidemiologic analyses provide valuable insight into thyroid outcomes among GLP-1 users
Routes of Drug Administration Chapter 6 Giovannitti JA, Trapp LD (1991) Adult sedation: oral, rectal, IM, IV